Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > A Study of the Investigational Targeted Therapy ART4215 to Treat Advanced or Metastatic Solid Tumors
Printer Friendly Page A Study of the Investigational Targeted Therapy ART4215 to Treat Advanced or Metastatic Solid Tumors

A Study of the Investigational Targeted Therapy ART4215 to Treat Advanced or Metastatic Solid Tumors

Clinicaltrials.gov identifier:
NCT04991480


Advanced solid tumors

Study Contact Information:

Study coordinator:
Michael Courtland
[email protected]


A Study of the Investigational Targeted Therapy ART4215 to Treat Advanced or Metastatic Solid Tumors

About the Study

This study is looking at how well a drug called ART4215 works either alone or when combined with the talazoparib in people with different types of advanced cancers. ART4215 is an oral, that is designed to keep cancer cells from repairing damage. 

This study is no longer recruiting patients. 

This Study is Open To:

This study is no longer recruiting patients. 

This Study is Not Open To:

This study is no longer recruiting patients.